Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System
18 août 2021 17h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system. Identity...
Conformis Reports Second Quarter 2021 Financial Results
04 août 2021 16h05 HE
|
Conformis, Inc.
BILLERICA, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release Second Quarter 2021 Financial Results on August 4, 2021
01 juil. 2021 17h00 HE
|
Conformis, Inc.
BILLERICA, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the second quarter ended June 30, 2021 after the...
Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
18 mai 2021 08h15 HE
|
Conformis, Inc.
BILLERICA, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System
10 mai 2021 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee...